Product dossierBuilt from registrations, label text and platform-curated data

巨子交联重组胶原蛋白植入剂

巨子 is a Collagen product (Class III device), registered by 陕西巨子生物技术有限公司. Linked registrations: China 国械注准20263131219. First approved in China on 2026-06-16 (国械注准20263131219). Data as of 2026-10-24.

  • Regulatory classCollagen · Class III device
  • Holder陕西巨子生物技术有限公司
  • JurisdictionsCN
  • Updated2026-10-24 · v1

Registration and basics are public; findings and prices need an account

Registration and basics

巨子

Product
Regulatory class
Class III device
Category
Collagen
China · NMPA device registration
国械注准20263131219
Name on registration
交联重组胶原蛋白植入剂
Registrant
陕西巨子生物技术有限公司
First approval
2026-06-16
This certificate issued
2026-06-16
Valid until
2031-06-15
Models and sizes
型号:T3型,规格:0.5mL/支,1.0mL/支,1.5mL/支,2.0mL/支
Checked against official page
2026-10-23

Public: fields from the registration record.

Label facts by jurisdiction

What each jurisdiction's label says for the same attribute; gaps are marked Not reported, irrelevant ones N/A

No data yet

Registration timeline

  1. CN

    国械注准20263131219 first approved

  2. CN

    国械注准20263131219 change

    首次获批(受理号 CQZ2402149;2026年06月17日医疗器械批准证明文件送达信息)

  3. CN

    国械注准20263131219 valid until

First approval, this certificate's issue date (updated after renewals or changes), changes and expiry are listed separately; a missing first approval means it was not obtained from an official source. Up to 6 recent changes per registration; click the number for the full record.

Cross findings · Price observations

Sign in to see findings and prices

Findings and prices stay out of indexable pages.

Sign in to view

Recent changes

1
  • 国械注准20263131219: 首次获批(受理号 CQZ2402149;2026年06月17日医疗器械批准证明文件送达信息)2026-06-16

Sources

1